VolitionRx Limited is a multi-national company which develops new ways to detect cancer. Their ideal product needed to be reliable, efficient, and easily manageable for their modestly-sized IT department. Additionally, the solution had to be readily deployable to their operations in four separate countries. According to Daniel Halter, Group IT Manager at Volition, traditional antivirus vendors were “offering the same old solution only slightly jazzier. The model they were offering, although new, was and is the same thing that has been around for a while.” Daniel also stated that Volition had little time to determine which vendors are “selling the truth and which ones are selling the dreams.” Seeking an ideal match, Daniel reached out to Khipu Networks for their security recommendation. Khipu Networks suggested CylancePROTECT®, Cylance’s artificial intelligence endpoint security product. Read the full case study to learn about the results Cylance was able to deliver.